Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression
- 10 December 2006
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 312 (20) , 4120-4138
- https://doi.org/10.1016/j.yexcr.2006.09.019
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (ES 11804, P30 ES 09089, P42 ES 10349)
- National Institute of Environmental Health Sciences
This publication has 69 references indexed in Scilit:
- Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cellsExperimental Cell Research, 2006
- A phase II trial of arsenic trioxide in patients with metastatic melanomaCancer, 2005
- Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-induced ApoptosisJournal of Biological Chemistry, 2004
- p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanomaCancer Gene Therapy, 2002
- Regulation of TRAIL Expression by the Phosphatidylinositol 3-Kinase/Akt/GSK-3 Pathway in Human Colon Cancer CellsJournal of Biological Chemistry, 2002
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- The involvement of NF-κB in the constitutive overexpression of cyclooxygenase-2 in cyclooxygenase-1 null cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2002
- Isolation and Molecular Characterization of the 5′-Upstream Region of the Human TRAIL GeneBiochemical and Biophysical Research Communications, 2000